{"pmid": "11398072", "sentences": {"sent_1": {"Section": "", "text": "METHODS : This study was a randomized , double - blind , placebo - controlled study in 62 subjects involving 12 once weekly nebulizations of 0.75 , 1.5 , or 3.0 mg of IL - 4R or placebo .", "entities": {"entity_1": {"text": "placebo", "class": "Intervention", "negation": 0, "UMLS": "C0032042:placebo,", "index": 1, "start": 12}, "attribute_1": {"text": "12 once weekly nebulizations of 0.75 , 1.5 , or 3.0 mg", "class": "measure", "negation": 0, "UMLS": "C1659427:nebulization,", "index": 2, "start": 20}, "entity_2": {"text": "IL - 4R", "class": "Participant", "negation": 0, "UMLS": "", "index": 3, "start": 33}, "entity_3": {"text": "placebo", "class": "Intervention", "negation": 0, "UMLS": "C0032042:placebo,", "index": 4, "start": 37}}, "relations": {}}, "sent_2": {"Section": "", "text": "During screening , subjects documented dependence on inhaled corticosteroids by an exacerbation in asthma induced by one or two 50 % dose reductions at 2 - week intervals .", "entities": {"entity_4": {"text": "dependence", "class": "Outcome", "negation": 0, "UMLS": "C0439857:dependence,", "index": 1, "start": 5}, "entity_5": {"text": "inhaled corticosteroids", "class": "Outcome", "negation": 0, "UMLS": "C0001617:corticosteroids,C0004048:inhaled,", "index": 2, "start": 7}, "entity_6": {"text": "exacerbation", "class": "Outcome", "negation": 0, "UMLS": "C4086268:Exacerbation,", "index": 3, "start": 11}, "entity_7": {"text": "asthma", "class": "Participant", "negation": 0, "UMLS": "C0004096:asthma,", "index": 4, "start": 13}, "attribute_2": {"text": "50 % dose reductions", "class": "measure", "negation": 0, "UMLS": "C0441610:reductions,", "index": 5, "start": 19}, "attribute_3": {"text": "reductions", "class": "modifier", "negation": 0, "UMLS": "C0441610:reductions,", "index": 6, "start": 22}}, "relations": {}}, "sent_3": {"Section": "", "text": "After restabilization for 2 weeks on the dose above which their asthma flared , inhaled steroids were discontinued , patients were randomized , and study medication was started on day 0 .", "entities": {"entity_8": {"text": "restabilization", "class": "Participant", "negation": 0, "UMLS": "C1293130:stabilization,", "index": 1, "start": 1}, "entity_9": {"text": "asthma flared", "class": "Outcome", "negation": 0, "UMLS": "C0004096:asthma,", "index": 2, "start": 11}, "entity_10": {"text": "inhaled steroids", "class": "Intervention", "negation": 0, "UMLS": "C2065041:inhaled steroids,", "index": 3, "start": 14}}, "relations": {}}}}